SCHEMBL7248994

SCHEMBL7248994

C[C@H](N)C(=O)Oc1ccccc1NC(=O)OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
BRD4 O60885 1/20 0.49
PLAU P00749 1/20 0.46
CASP3 P42574 1/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
ACHE P22303 2/20 0.45
MAOB P27338 1/20 0.44
LTA4H P09960 1/20 0.44
ATM Q13315 1/20 0.44
MGLL Q99685 1/20 0.44
PTPN1 P18031 1/20 0.44
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7585707 0.82 TP53 (0.62) NPC1RAB9APOLBKMT2AMAOB
SCHEMBL7235274 0.81 KDM4E (0.54) NPC1RAB9APOLBKMT2ASMN1; SMN2
SCHEMBL28184488 0.80 NPC1 (0.56) NPC1RAB9ABRD4CASP3POLB
SCHEMBL4064899 0.77 ALDH1A1 (0.55) NPC1RAB9ACASP3POLBKMT2A
Benzyl Phenylcarbamate SCHEMBL8606871 0.77 POLB (0.62) NPC1RAB9APOLBMAOBLTA4H
SCHEMBL5497597 0.77 ALDH1A1 (0.42) NPC1RAB9APOLBKMT2AL3MBTL1
SCHEMBL7310630 0.76 NPC1 (0.61) NPC1RAB9ABRD4PLAUCASP3
SCHEMBL7319476 0.76 CTSL (0.52)
SCHEMBL2135198 0.75 ALDH1A1 (0.60) KMT2AL3MBTL1CA1CA2LTA4H
SCHEMBL313062 0.75 ALDH1A1 (0.60) KMT2AL3MBTL1CA1CA2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6569847-B1 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease NAEJA PHARMACEUTICALS INC. (CA) 2003-05-27 US disclosed
EP-1165506-A1 SUBSTITUTED AZETIDIN-2-ONES AS CYSTEINE PROTEASE INHIBITORS Naeja Pharmaceutical Inc. (CA) 2002-01-02 EP disclosed
WO-2000059881-A1 SUBSTITUTED AZETIDIN-2-ONES AS CYSTEINE PROTEASE INHIBITORS NAEJA PHARMACEUTICAL INC (CA) 2000-10-12 WO disclosed